Relia Tech/小鼠VEGF-A ELISA(总)/96孔/BMS619/2

价格
¥9500.00
货号:BMS619/2
浏览量:127
品牌:Relia Tech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat-Nr.BMS619/2
Size96 well
Price475 €
Formulationbox containing complete ELISA set
SynonymsVEGFA; VPF; VEGF; MVCD1
DescriptionVascular endothelial growth factor (VEGF or VEGF-A), also known as vascular permeability factor (VPF) or vasculotropin, is a homodimeric 34 - 42 kDa, heparin-binding glycoprotein with potent angiogenic, mitogenic and vascular permeability-enhancing activities specific for endothelial cells. Different isoforms can be generated by differential splicing (e.g. VEGF165). All eight cysteine residues involved in intra- and inter-chain disulfide bonds are conserved among these growth factors. A cDNA encoding a protein having a 53% amino acid sequence homology in the PDGF-like region of VEGF has been isolated from a human placental cDNA library. This protein, named placenta growth factor (PlGF), is now recognized to be a member of the VEGF family of growth factors. Two receptor tyrosine kinases have been described as putative VEGF receptors. Flt-1 (fms-like tyrosine kinase), and KDR (kinase-insert-domain-containing receptor) proteins have been shown to bind VEGF-A with high affinity. In vitro, VEGF is a potent endothelial cell mitogen. In cultured endothelial cells, VEGF can activate phospholipase C and induce rapid increases of free cytosolic Ca2+. VEGF has also been shown to be chemotactic for monocytes and osteoblasts. In vivo, VEGF can induce angiogenesis as well as increase microvascular permeability. As a vascular permeability factor, VEGF acts directly on the endothelium and does not degranulate mast cells. Based on its in vitro and in vivo properties, VEGF is expected to play important roles in inflammation and during normal and pathological angiogenesis, a process that is associated with wound healing, embryonic development, and growth and metastasis of solid tumors. For research use only. Not for diagnostic or therapeutic procedures.
RELIATech为在昆虫细胞(杆状病毒)和大肠杆菌中表达重组蛋白提供全面的客户服务。这些服务分为一系列步骤,可以单独执行或组合执行,以便您可以选择实际需要的步骤。这些服务旨在充分满足您的大多数需求,从将基因克隆到杆状病毒转移载体或大肠杆菌表达载体,重组杆状病毒或大肠杆菌菌株的产生到重组蛋白的生产和纯化。如果需要,我们还将尝试建立一种测定纯化蛋白的生物学活性的方法。